News & insights

The Partnership for Maternal, Newborn and Child Health (PMNCH) is the world’s largest alliance for women’s, children’s and adolescents’ health and well-being, with +1,300 partner organisations working together through 10 constituency groups. CEPA was commissioned by the PMNCH Board to conduct an external evaluation of PMNCH. The evaluation was of strategic importance in the context of developing the next Strategic Plan for PMNCH for the period 2021-2025.  

The evaluation focused on the five themes of (i) vision and mission; (ii) governance and accountability; (iii) programming and delivery; (iv) partner and country engagement; and (v) effectiveness, performance and impact.  

The evaluation used a mixed methods approach, incorporating qualitative and quantitative components, and had a retrospective and prospective orientation. The methodology drew on ten data collection processes: (i) desk-based documentation review; (ii) high level strategic discussions, including participation in the PMNCH November 2019 Board meeting; (iii) key informant interviews; (iv) constituency-based group consultations; (v) a partnership e-based open enquiry; (vi) country case studies; (vii) a social network analysis; (viii) a partnership database analysis; (ix) a funding analysis, and; (x) an analysis of the strengths, weaknesses, opportunities and threats (SWOT) of global health partnerships. 

The evaluation contributed to, and was used in conjunction with, other evaluations and review work. Taken together, these works aimed to provide an independent and reasoned view on the continued relevance and validity of the Partnership’s mandate and mission, its governance structure and approach, its achievements and the effectiveness and impact of programming from 2014 through 2019. It also looked towards 2025.

The Final Report can be downloaded from here.